Location History:
- Constance, DE (1976)
- LATE OF Constance, DE (1977)
- Konstanz, DE (1977)
Company Filing History:
Years Active: 1976-1977
Title: Erhard Langenscheid: Innovator in Pharmaceutical Chemistry
Introduction
Erhard Langenscheid is a notable inventor based in Constance, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of therapeutically active compounds. With a total of 3 patents to his name, Langenscheid's work focuses on innovative solutions for medical treatments.
Latest Patents
Langenscheid's latest patents include the development of substituted N-acyl-N'-(3-amino-2-cyanoacryloyl-)formamidrazones. These compounds are recognized for their therapeutic activity and pharmacological acceptability, specifically in inhibiting xanthine oxidase. They serve as active ingredients in medicaments for the treatment of gout. Another significant patent involves 4(1H)-pyrimidinones, which are also therapeutically active and pharmacologically acceptable. These compounds are prepared by treating 2-(acyl) hydrazonomethyl-3-chloro or hydroxy-4-aza-2,4-pentadienenitriles with acid, and they too are useful in gout treatment.
Career Highlights
Erhard Langenscheid is currently associated with Byk Gulden Lomberg Chemische Fabrik GmbH, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments for gout, showcasing his commitment to improving patient care through scientific research.
Collaborations
Langenscheid collaborates with Kurt Klemm, contributing to the development of new pharmaceutical solutions. Their partnership exemplifies the importance of teamwork in the field of innovation.
Conclusion
Erhard Langenscheid's contributions to pharmaceutical chemistry highlight his role as a key inventor in the industry. His innovative patents and ongoing work at Byk Gulden Lomberg Chemische Fabrik GmbH demonstrate his dedication to advancing medical treatments.